119 related articles for article (PubMed ID: 27511216)
1. Potential drug-drug interactions in hospitalised haematological patients.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Sánchez Salinas A; de la Rubia Nieto A; Miró AE
J Oncol Pharm Pract; 2017 Sep; 23(6):443-453. PubMed ID: 27511216
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.
Fernández de Palencia Espinosa MA; Díaz Carrasco MS; Fuster Soler JL; Ruíz Merino G; De la Rubia Nieto MA; Espuny Miró A
Int J Clin Pharm; 2014 Dec; 36(6):1160-9. PubMed ID: 25204258
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
4. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
5. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
6. Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice.
Lempers VJ; Martial LC; Schreuder MF; Blijlevens NM; Burger DM; Aarnoutse RE; Brüggemann RJ
Curr Opin Pharmacol; 2015 Oct; 24():38-44. PubMed ID: 26218924
[TBL] [Abstract][Full Text] [Related]
7. Azole antimycotics and drug interactions in the perioperative period.
Saari TI; Olkkola KT
Curr Opin Anaesthesiol; 2010 Aug; 23(4):441-8. PubMed ID: 20610983
[TBL] [Abstract][Full Text] [Related]
8. Potential drug-drug interactions in hospitalized patients undergoing systemic chemotherapy: a prospective cohort study.
Stoll P; Kopittke L
Int J Clin Pharm; 2015 Jun; 37(3):475-84. PubMed ID: 25711852
[TBL] [Abstract][Full Text] [Related]
9. Update on drug interactions with azole antifungal agents.
Lomaestro BM; Piatek MA
Ann Pharmacother; 1998 Sep; 32(9):915-28. PubMed ID: 9762380
[TBL] [Abstract][Full Text] [Related]
10. Drug-drug interactions of cytostatics with regular medicines in lung cancer patients.
Rompelman FM; Smit AA; Franssen EJ; Crul M
J Oncol Pharm Pract; 2017 Oct; 23(7):483-490. PubMed ID: 27530243
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients.
Billaud EM; Guillemain R; Berge M; Amrein C; Lefeuvre S; Louët AL; Boussaud V; Chevalier P
Med Mycol; 2010 Nov; 48 Suppl 1():S52-9. PubMed ID: 21067331
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
13. Azoles and antidepressants: a mini-review of the tolerability of co-administration.
Roussos P; Lewis RE; Kontoyiannis DP
Mycoses; 2009 Sep; 52(5):433-9. PubMed ID: 19207836
[TBL] [Abstract][Full Text] [Related]
14. Azole interactions with multidrug therapy in pediatric oncology.
Ruggiero A; Arena R; Battista A; Rizzo D; Attinà G; Riccardi R
Eur J Clin Pharmacol; 2013 Jan; 69(1):1-10. PubMed ID: 22660443
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
16. Prevalence study on potential drug-drug interaction in cancer patients in Piacenza hospital's Onco-Haematology department.
Vecchia S; Orlandi E; Confalonieri C; Damonti E; Riva A; Sartori A; Cavanna L
J Oncol Pharm Pract; 2018 Oct; 24(7):490-493. PubMed ID: 28714379
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
19. [Positive interaction between immunosuppressive and antifungal drugs].
Rammaert B; Lortholary O
Med Sci (Paris); 2010; 26(8-9):747-52. PubMed ID: 20819713
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
